| Item Type | Name |
|
Concept
|
Age Factors
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Maryland
|
|
Concept
|
PPAR alpha
|
|
Concept
|
Maleimides
|
|
Concept
|
Elastin
|
|
Concept
|
Informed Consent
|
|
Concept
|
Magnetic Resonance Imaging, Cine
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Ankyrins
|
|
Concept
|
Receptor, Angiotensin, Type 2
|
|
Concept
|
Mitochondria
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Simethicone
|
|
Concept
|
Incidence
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Morbidity
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Age of Onset
|
|
Concept
|
Receptors, Transforming Growth Factor beta
|
|
Concept
|
Tissue Donors
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Anthracyclines
|
|
Concept
|
Single-Blind Method
|
|
Concept
|
Registries
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Confidence Intervals
|
|
Concept
|
Thrombocytopenia
|
|
Concept
|
Myosin Heavy Chains
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Interviews as Topic
|
|
Concept
|
Apoptosis Inducing Factor
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Societies, Medical
|
|
Concept
|
Family
|
|
Concept
|
Magnetic Resonance Angiography
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Statistics as Topic
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Nuclear Envelope
|
|
Concept
|
Boston
|
|
Concept
|
Multilevel Analysis
|
|
Concept
|
Mortality
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Propranolol
|
|
Concept
|
Sarcomeres
|
|
Concept
|
Smad2 Protein
|
|
Concept
|
Syncope
|
|
Concept
|
Observer Variation
|
|
Concept
|
Stroke Volume
|
|
Concept
|
Logistic Models
|
|
Concept
|
Prealbumin
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Sodium
|
|
Concept
|
Early Termination of Clinical Trials
|
|
Concept
|
Linear Models
|
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
|
Concept
|
Echocardiography
|
|
Concept
|
Scleroderma, Systemic
|
|
Concept
|
Matrix Metalloproteinase 9
|
|
Concept
|
Sodium Channels
|
|
Concept
|
Matrix Metalloproteinase 2
|
|
Concept
|
Polycystic Kidney, Autosomal Dominant
|
|
Concept
|
Sarcoidosis
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Models, Statistical
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Mitogen-Activated Protein Kinase 14
|
|
Concept
|
Quality of Life
|
|
Concept
|
Professional-Family Relations
|
|
Concept
|
Cicatrix
|
|
Concept
|
Signal Transduction
|
|
Concept
|
Heart Rate
|
|
Concept
|
RNA Splice Sites
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Survival Rate
|
|
Concept
|
Expert Testimony
|
|
Concept
|
MAP Kinase Signaling System
|
|
Concept
|
Likelihood Functions
|
|
Concept
|
Primary Prevention
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Calpain
|
|
Concept
|
Glucuronidase
|
|
Concept
|
Heart-Assist Devices
|
|
Concept
|
Ventricular Function, Left
|
|
Concept
|
Protein Modification, Translational
|
|
Concept
|
Mitogen-Activated Protein Kinase 8
|
|
Concept
|
Fatal Outcome
|
|
Concept
|
Cause of Death
|
|
Concept
|
Plakophilins
|
|
Concept
|
Diabetic Neuropathies
|
|
Concept
|
Neutralization Tests
|
|
Concept
|
Microsatellite Repeats
|
|
Concept
|
alpha-Galactosidase
|
|
Concept
|
Positron-Emission Tomography
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Systole
|
|
Concept
|
Sex Factors
|
|
Concept
|
Respiration, Artificial
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Molecular Diagnostic Techniques
|
|
Concept
|
Cetrimonium Compounds
|
|
Concept
|
Troponin T
|
|
Concept
|
Smad4 Protein
|
|
Concept
|
Diuresis
|
|
Concept
|
Amyloidosis
|
|
Concept
|
Protein Structure, Quaternary
|
|
Concept
|
Interferon-alpha
|
|
Concept
|
Friedreich Ataxia
|
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
|
Concept
|
Physical Endurance
|
|
Concept
|
Mass Screening
|
|
Concept
|
Ehlers-Danlos Syndrome
|
|
Concept
|
Graft Rejection
|
|
Concept
|
Prevalence
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Body Surface Potential Mapping
|
|
Concept
|
Induced Pluripotent Stem Cells
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Baltimore
|
|
Concept
|
Sweat Glands
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Fabry Disease
|
|
Concept
|
Amyloid Neuropathies, Familial
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Activin Receptors, Type I
|
|
Concept
|
Sequence Homology, Amino Acid
|
|
Concept
|
Skull
|
|
Concept
|
Collagen
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Arteriovenous Malformations
|
|
Concept
|
Proteomics
|
|
Concept
|
Consensus
|
|
Concept
|
RNA Splicing
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Farnesyltranstransferase
|
|
Concept
|
Transfection
|
|
Concept
|
Sulfones
|
|
Concept
|
Pluripotent Stem Cells
|
|
Concept
|
Trust
|
|
Concept
|
United States
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Ultrasonography
|
|
Concept
|
Gene Deletion
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Skin Neoplasms
|
|
Concept
|
Tachycardia, Ventricular
|
|
Concept
|
Cardiac Myosins
|
|
Concept
|
Skin
|
|
Concept
|
Risk
|
|
Concept
|
Lamin Type A
|
|
Concept
|
Risk Factors
|
|
Concept
|
Young Adult
|
|
Concept
|
Tachycardia, Sinus
|
|
Concept
|
Sweden
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Zebrafish
|
|
Concept
|
Siblings
|
|
Concept
|
Anthracenes
|
|
Concept
|
Rats, Transgenic
|
|
Concept
|
Age Distribution
|
|
Concept
|
Troponin I
|
|
Academic Article
|
Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis.
|
|
Academic Article
|
The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging.
|
|
Academic Article
|
Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.
|
|
Academic Article
|
Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy.
|
|
Academic Article
|
A Pkd1-Fbn1 genetic interaction implicates TGF-? signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
|
|
Academic Article
|
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.
|
|
Academic Article
|
Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
|
|
Academic Article
|
Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
|
|
Academic Article
|
Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
|
|
Academic Article
|
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
|
|
Academic Article
|
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.
|
|
Academic Article
|
Familial amyloid cardiomyopathy due to TTR mutations: an underdiagnosed cause of restrictive cardiomyopathy [corrected].
|
|
Academic Article
|
Absence of a Primary Role for SCN10A Mutations in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
|
|
Academic Article
|
Comprehensive Versus Targeted Genetic Testing in Children with Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Familial hypertrophic cardiomyopathy associated with cardiac beta-myosin heavy chain and troponin I mutations.
|
|
Academic Article
|
Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation.
|
|
Academic Article
|
Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
|
|
Academic Article
|
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
|
|
Academic Article
|
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid?Cardiomyopathy.
|
|
Academic Article
|
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
|
|
Academic Article
|
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
|
|
Concept
|
Wnt Signaling Pathway
|
|
Concept
|
NAV1.5 Voltage-Gated Sodium Channel
|
|
Concept
|
NAV1.8 Voltage-Gated Sodium Channel
|
|
Concept
|
Connectin
|
|
Concept
|
Protein Kinase C beta
|
|
Concept
|
Mouse Embryonic Stem Cells
|
|
Concept
|
Sildenafil Citrate
|
|
Concept
|
Fibrillins
|
|
Concept
|
Fibrillin-1
|
|
Concept
|
Protein Domains
|
|
Concept
|
Mice, 129 Strain
|